Trilaciclib is a member of piperazines and a member of pyridines. Trilaciclib is a Kinase Inhibitor. The mechanism of action of trilaciclib is as a Cyclin-dependent Kinase 4 Inhibitor, and Cyclin-dependent Kinase 6 Inhibitor, and Organic Cation Transporter 2 Inhibitor, and Multidrug and Toxin Extrusion Transporter 1 Inhibitor, and Multidrug and Toxin Extrusion Transporter 2 K Inhibitor. It is grouped under the following drug class(es): CDK4/6 Inhibitors. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include trilaciclibum and Cosela. Its PubChem CID is 68029831.
Trilaciclib
| CAS No | 1374743-00-6 |
|---|---|
| Molecular Formula | C24H30N8O |
| Molecular Weight | 446.5 g/mol |
| Synonyms | 4-[[5-(4-methylpiperazin-1-yl)pyridin-2-yl]amino]spiro[1,3,5,11-tetrazatricyclo[7.4.0.02,7]trideca-2,4,6,8-tetraene-13,1′-cyclohexane]-10-one |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Trilaciclib is a member of piperazines and a member of pyridines. Trilaciclib is a Kinase Inhibitor.
The listed CAS number is 1374743-00-6.
The listed molecular formula is C24H30N8O.
The listed molecular weight is 446.5 g/mol.
4-[[5-(4-methylpiperazin-1-yl)pyridin-2-yl]amino]spiro[1,3,5,11-tetrazatricyclo[7.4.0.02,7]trideca-2,4,6,8-tetraene-13,1′-cyclohexane]-10-one.
The source lists trilaciclibum and Cosela.